XML 63 R51.htm IDEA: XBRL DOCUMENT v3.22.1
Supplemental Quarterly Information (Unaudited) (Tables)
 12 Months Ended
Dec. 31, 2021
Supplemental Quarterly Information (Unaudited) [Abstract]  
Supplemental Quarterly Information
The following tables reflect the Company’s unaudited condensed consolidated statements of operations for each of the quarterly periods in 2021 and 2020 (in USD except for number of shares):

   
Three Months Ended,
  
   
December 31,
2021
    
September 30,
2021
    
June 30,
2021
    
March 31,
2021
  
Revenue
  
$
2,902,088
    
$
1,673,998
    
$
1,003,464
    
$
1,489,292
  
Cost of revenue
    
(2,743,740
)
    
(1,645,781
)
    
(669,352
)
    
(347,342
)
Gross profit
    
158,348
      
28,217
      
334,112
      
1,141,950
  
Income from grants
    
197,420
      
507,606
      
85,727
      
38,453
  
Research and development expenses
    
(1,979,491
)
    
(893,215
)
    
(638,753
)
    
(29,082
)
Administrative and selling expenses
    
(14,318,499
)
    
(13,040,649
)
    
(6,595,735
)
    
(7,921,858
)
Amortization of intangible assets
    
(717,383
)
    
(309,734
)
    
29,047
      
(186,760
)
Operating loss
    
(16,659,605
)
    
(13,707,775
)
    
(6,785,602
)
    
(6,957,297
)
Fair value change of warrant liability
    
6,909,723
      
2,421,874
      
3,645,835
      
9,765,625
  
Finance expenses, net
    
(24,600
)
    
(13,542
)
    
(3,139
)
    
(10,280
)
Foreign exchange losses, net
    
(40,567
)
    
(15,256
)
    
(10,839
)
    
23,955
  
Other (expenses) income, net
    
(62,508
)
    
(15,960
)
    
10,435
      
83,671
  
(Loss) income before income taxes
    
(9,877,557
)
    
(11,330,659
)
    
(3,143,310
)
    
2,905,674
  
Income taxes
    
871,575
      
50,935
      
-
      
-
  
Net (loss) income
  
$
(9,005,982
)
  
$
(11,279,724
)
  
$
(3,143,310
)
  
$
2,905,674
  
Net (loss) income per share
                                
Basic (loss) income per share
  
$
(0.18
)
  
$
(0.23
)
  
$
(0.07
)
  
$
0.08
  
Basic weighted average number of shares
    
51,253,591
      
48,325,164
      
46,126,490
      
37,769,554
  
Diluted (loss) income per share
  
$
(0.18
)
  
$
(0.23
)
  
$
(0.07
)
  
$
0.07
  
Diluted weighted average number of shares
    
51,253,591
      
48,325,164
      
46,126,490
      
40,987,346
  

   
Three Months Ended,
  
   
December 31,
2020
    
September 30,
2020
    
June 30, 2020
    
March 31, 2020
  
Revenue
  
$
356,620
    
$
225,412
    
$
200,354
    
$
100,266
  
Cost of revenue
    
(139,388
)
    
(90,477
)
    
(217,916
)
    
(66,037
)
Gross profit
    
217,232
      
134,935
      
(17,562
)
    
34,229
  
Income from grants
    
47,646
      
16,076
      
54,828
      
88,278
  
Research and development expenses
    
(21,265
)
    
(37,640
)
    
-
      
(43,633
)
Administrative and selling expenses
    
(1,905,793
)
    
(886,629
)
    
(444,129
)
    
(310,305
)
Operating loss
    
(1,662,180
)
    
(773,258
)
    
(406,863
)
    
(231,431
)
Finance income / (expenses), net
    
(793
)
    
(1,712
)
    
(514
)
    
(2,523
)
Foreign exchange losses, net
    
512
      
(8,005
)
    
8
      
(18,587
)
Other expenses, net
    
(40,544
)
    
31,058
      
98,351
      
(104,561
)
Loss before income taxes
    
(1,703,005
)
    
(751,917
)
    
(309,018
)
    
(357,102
)
Income taxes
    
-
      
3,101
      
(3,101
)
    
-
  
Net loss
  
$
(1,703,005
)
  
$
(748,816
)
  
$
(312,119
)
  
$
(357,102
)
Net loss per share
                                
Basic loss per share
  
$
(0.07
)
  
$
(0.03
)
  
$
(0.02
)
  
$
(0.02
)
Basic weighted average number of shares
    
25,033,398
      
23,182,817
      
18,736,370
      
14,979,803
  
Diluted loss per share
  
$
(0.07
)
  
$
(0.03
)
  
$
(0.02
)
  
$
(0.02
)
Diluted weighted average number of shares
    
25,033,398
      
23,182,817
      
18,736,370
      
14,979,803